HIGHLIGHTS
- who: Yunfei Li and colleagues from the Department of Biomedical Engineering, The City College of the City University of New York, New York, NY, USA have published the research: Inhibition of Abl Kinase by Imatinib Can Rescue the Compromised Barrier Function of 22q11.2DS Patient-iPSC-Derived Blood-Brain Barriers, in the Journal: Cells 2023, 422 of 25/01/2023
- what: The authors showed that imatinib, an inhibitor of Abl kinase, can rescue the The study provides much more detail on the molecular mechanism for understanding the anti-vascular leak effect of imatinib. For the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.